Hilton Boston Logan Airport, One Hotel Drive, Boston, Massachusetts, 02128, United States
The 3rd ADC Target Selection Summit is the industry-specific event focusing on the latest developments in ADC target selection. With a spotlight on identifying and validating novel targets and exploring novel linker-payload technologies, this summit connects ADC enthusiasts in biology, discovery, and translational fields. Gain insights from leading experts, inform your target selection strategies, and balance risk in your ADC pipeline for 2024 and beyond. Don't miss this unique opportunity to enhance your drug development process. Join the summit on December 5-7, 2023, and connect with peers from prominent organizations.
Bringing together technical case studies with actionable insights, the 2nd TPD Assay Development and Screening Summit returns as the first and only industry-dedicated conference to support in-house assay development and screening strategies to find new targets, uncover novel ligands, unravel the MOA, progress beyond CRBN and VHL, improve high throughput methods and progress from early discovery to drug candidate with scalable compounds.
With promise shown using technologies like DELs, CryoEM and HDX-MS, join us as we take a deep dive into the persisting challenges holding back the progression of candidates into pre-clinical studies by exploring the best methodologies at your disposal across AI/ML guided structure-based drug design, proteomics-led, or cell-based assay approaches.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our